Home » Merve Demir

Merve Demir

Merve Demir

 

Education:

B.S. Chemical Engineering, B.S. Chemistry, Bogazici University 2016

From: Istanbul, Turkey

Joined the David Lab: January 2017

Outside of lab: I love traveling, hiking, cooking and spending time with my family and friends.

 

 

Research in David Lab:

My work in the David lab focuses on elucidating the working mechanism of DNA glycosylase MutY. This enzyme can recognize the OG:A mispair and cleave the adenine from the DNA allowing other enzymes in the base excision repair pathway to restore the integrity of the DNA. Deficiency in repair of the OG:A mispair has been linked to a syndrome known as MUTYH-Associated Polyposis (MAP) that predisposes individuals to colorectal cancer. By elucidating the mechanism of the enzyme, we can gain insight into how MAP variants related to this syndrome have altered activities.

Recently proposed mechanism of the enzyme by the David lab involves formation of a covalent intermediate that stabilizes the oxacarbenium ion intermediate after the cleavage of the adenine. This allows release of the adenine through an exit channel in the active site. In order to confirm the formation of the covalent intermediate and the mode of release of the adenine from the active site, I use a range of different experimental techniques from synthesis of transition state analogs to biochemical and crystallographic studies of the enzyme.

Previous Research Experience:

As an undergrad, I worked in Dr. Duygu Avci’s lab at Bogazici University to synthesize a phophonate containing dental monomer with properties such as high polymerization rate, hydrolytic stability and ability to form favorable interactions with the tooth material. I also worked in Fujimoto Research Group at Keio University as a summer trainee where I worked on solid and solution phase synthesis of fluorescent-labeled lipopeptide as TLR2 ligand. In my senior year, I worked in Aviyente Research Group at Bogazici University doing quantum mechanical calculations of Diels-Alder reactions in ionic liquids and in Pemra Doruker’s lab at Bogazici University exploring ligand binding sites of glycolytic enzymes in different species by using computational solvent mapping.

RSS Science Daily News

  • Why Alzheimer’s attacks the brain’s memory hub first September 3, 2025
    Virginia Tech researchers are investigating how overloaded mitochondria in the brain’s memory circuits may spark early Alzheimer’s damage. Their work focuses on calcium signaling and how it might trigger breakdowns in the entorhinal cortex.
  • Warped planet nurseries rewrite the rules of how worlds are born September 3, 2025
    Astronomers using ALMA have discovered that planet-forming discs are not flat and serene but subtly warped, reshaping our understanding of how planets form. These slight tilts, similar to those seen among planets in our Solar System, suggest that planetary systems emerge in more chaotic and dynamic conditions than once believed. The findings point to new […]
  • Distant suns covered in dark spots could shape the search for life September 2, 2025
    A new model called StarryStarryProcess lets scientists map star spots with precision, improving how exoplanets are studied. By factoring in both transits and stellar rotation, it provides richer details about stars and their influence on planetary signals.
  • NASA’s SPHEREx Captures Comet 3I/ATLAS, a Visitor From Beyond the Solar System September 2, 2025
    NASA’s SPHEREx joined Webb and Hubble in studying interstellar comet 3I/ATLAS, gathering data on its size, chemistry, and physical traits. While harmless to Earth, the comet provides scientists a rare opportunity to learn more about solar system wanderers.
  • Scientists discover how to wipe out breast cancer’s hidden cells September 2, 2025
    Scientists at the University of Pennsylvania have shown for the first time that it’s possible to detect dormant cancer cells in breast cancer survivors and eliminate them with repurposed drugs, potentially preventing recurrence. In a clinical trial, existing medications cleared these hidden cells in most participants, leading to survival rates above 90%. The findings open […]

Contact:

Dr. Sheila S. David
ssdavid@ucdavis.edu
(530)-752-4280

Department of Chemistry
One Shields Ave.
Davis, CA 95616